- N62 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM N62 became effective on October 1, 2022.
- This is the American ICD-10-CM version of N62 – other international versions of ICD-10 N62 may differ.
ICD-10-CM N62 is grouped within Diagnostic Related Group(s):
Applicable To
- Gynecomastia
- Hypertrophy of breast NOS
- Massive pubertal hypertrophy of breast
Type 1 Excludes
- breast engorgement of newborn (P83.4)
- disproportion of reconstructed breast (N65.1)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to N62:
- development, breast > Excess, excessive, excessively
- nipple > epithelial L85.9
- breast > Hypertrophy, hypertrophic
- pubertal, massive > breast N62
- senile (parenchymatous) > breast N62
- nipple > Hypertrophy, hypertrophic